Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -110,114 | -76,184 | -40,649 | -279,818 | -225,355 |
| Depreciation Amortization | 12,184 | 1,878 | -7 | 4,176 | 3,563 |
| Accounts receivable | 9,594 | 6,622 | 6,703 | -3,706 | -2,049 |
| Other Working Capital | -8,149 | -767 | 1,478 | 19,834 | 6,921 |
| Other Operating Activity | -1,606 | -528 | -4,189 | 43,299 | 37,044 |
| Operating Cash Flow | $-98,090 | $-68,979 | $-36,665 | $-216,215 | $-179,875 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 61,663 | 67,156 | 13,226 | -248,529 | 58,389 |
| PPE Investments | 5,750 | 5,750 | 5,774 | -969 | -804 |
| Purchase Of Investment | N/A | N/A | N/A | -2,000 | -2,000 |
| Sale Of Investment | N/A | N/A | N/A | 361,084 | N/A |
| Investing Cash Flow | $67,413 | $72,906 | $19,000 | $109,586 | $55,585 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,624 | 2,915 | N/A | 83,238 | 76,570 |
| Other Financing Activity | -467 | -457 | -425 | -1,398 | -1,398 |
| Financing Cash Flow | $3,157 | $2,458 | $-425 | $81,841 | $75,173 |
| Exchange Rate Effect | -4 | -2 | -2 | -26 | -38 |
| Beginning Cash Position | 46,329 | 46,329 | 46,329 | 71,144 | 71,144 |
| End Cash Position | 18,805 | 52,713 | 28,238 | 46,329 | 21,988 |
| Net Cash Flow | $-27,525 | $6,383 | $-18,091 | $-24,814 | $-49,156 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,090 | -68,979 | -36,665 | -216,215 | -179,875 |
| Capital Expenditure | -321 | -321 | -297 | -969 | -804 |
| Free Cash Flow | -98,411 | -69,300 | -36,962 | -217,185 | -180,679 |